Johnson & Johnson Completes Acquisition of Shockwave Medical
Strengthens Position in Highest-Growth, Innovation-Oriented Segments of Cardiovascular Intervention Creates Greater Opportunity to Transform the Treatment Landscape... Read more.
Conduent Recognized as a Leader in 2024 NelsonHall Report on Multi-Process HR Transformation Services
FLORHAM PARK, N.J.–(BUSINESS WIRE)–Conduent Incorporated (Nasdaq: CNDT), a global technology-led business solutions and services company, today announced... Read more.
Rising Popularity: Spiral Accelerates Growth and Market Expansion Through New Financial Wellness Solutions
Spiral continues to gain momentum and popularity across banks and credit unions nationwide with new financial wellness and personalized banking products, including... Read more.
The Donerail Group Highlights Opportunity for Significant Value Creation at PENN Entertainment
Believes the Company’s Misguided Interactive Strategy and Poor Capital Allocation Have Destroyed Shareholder Value, Resulting in PENN Trading at a Steep Discount... Read more.
e4life, the New Frontier in the Battle Against Viruses Has Arrived in the United Kingdom Thanks to a Patented Italian Device Which Uses Electromagnetic Waves to Inactivate Them
BIRMINGHAM, United Kingdom–(BUSINESS WIRE)–As part of the MedTech Innovation Expo, the leading trade show in the medical device design and technology... Read more.
AstroNova to Report First-Quarter Fiscal 2025 Financial Results on Thursday, June 6
WEST WARWICK, R.I.–(BUSINESS WIRE)–AstroNova, Inc. (Nasdaq: ALOT), a global leader in data visualization technologies, will report its first-quarter... Read more.
PagerDuty to Present at Upcoming Conferences
SAN FRANCISCO–(BUSINESS WIRE)–PagerDuty, Inc. (NYSE:PD), a global leader in digital operations management, today announced that members of its management... Read more.
Mirum Pharmaceuticals Announces Positive CHMP Opinion for LIVMARLI® (maralixibat) Oral Solution for the Treatment of PFIC in Patients Three Months of Age and Older
Positive opinion from CHMP based on Phase 3 MARCH study with highly statistically significant (p<0.0001) reduction in pruritus severity between LIVMARLI vs. placebo... Read more.
PulteGroup, Inc. Announces Early Results of Tender Offers for Senior Notes
ATLANTA–(BUSINESS WIRE)–PulteGroup, Inc. (NYSE: PHM) (the “Company”) today announced the early tender results for its previously announced tender... Read more.
MBrace Therapeutics Presents Trial in Progress Poster for Lead Antibody-Drug Conjugate Program at 2024 ASCO Annual Meeting
SAN DIEGO–(BUSINESS WIRE)–#ADC–MBrace™ Therapeutics, Inc. (“MBrace”), a clinical-stage oncology company developing novel antibody-drug conjugates... Read more.